The purpose of this study was to determine the best estimate of glomerular filtration rate (GFr) to adjust vancomycin (vAn) dosage in critically ill patients. Seventy-eight adult intensive care unit patients received a 15 mg/kg loading dose of vAn plus a 30 mg/kg/day continuous infusion. Steady-state concentration was measured 48 hours later and the dose was adjusted to obtain a target concentration ranging from 20 to 25 mg/l. GFr was estimated by measured creatinine clearance (CL CR ), Cockcroft, Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations. The required dose providing the target concentration was 36±17 mg/kg/day. The first dosage had to be increased in 51% of all patients and in 84% of trauma patients (highest GFr), but had to be decreased in 17% of patients. The closest relationship between clearances of vancomycin was observed with CKD-ePI to GFr. The correlation between clearances of vancomycin and measured CL CR was significant but was rather poor with Cockcroft and Modification of Diet in renal Disease equation. on the Bland and Altman plots, measured CL CR provided a lower bias but a larger confidence interval and a weaker precision than CKD-ePI. For vAn dose adjustments in intensive care unit patients, Cockcroft formula and Modification of Diet in Renal Disease should be used with caution. In clinical practice, the physician does not have at their disposal the patient's measured CL CR when prescribing. The CKD-EPI appears to be the best predictor of clearances of vancomycin for calculation of a therapeutic VAN regimen.
Infections due to methicillin-resistant staphylococci are common in intensive care units (ICU). Among the antibiotics available, vancomycin remains an important bactericidal antibiotic for methicillinresistant staphylococcal infections 1 . Understanding its pharmacodynamic and pharmacokinetic properties is necessary for its use 2 . Vancomycin has a predominantly time-dependent bactericidal activity. Optimising the time during which the concentrations are a multiple of the Minimum Inhibitory Concentration (MIC) is still the best way to predict treatment success 3, 4 . Pharmacokinetic changes may also cause significant variability of serum concentrations, affecting both efficacy and toxicity 5 . Although clinical superiority of vancomycin by continuous infusion in terms of outcome has not been demonstrated, there is substantial theoretical support for continuous infusion, widely used in Europe 3, 4 . A loading dose prior to continuous infusion leads to a quicker achievement of target concentrations than intermittent administration. Ingram 6 showed that in adults with normal renal function, vancomycin by continuous infusion was associated with slower onset of nephrotoxicity. Some authors recommend a loading dose of 15 mg/kg of body weight followed by a daily dose of 30 mg/kg 7 . Target steady-state concentrations (Css) range from 20 to 25 mg/l 7, 8 . This guarantees an area under the curve between 0 and 24 hours greater than 400 mg/l/hour which seems correlated to efficacy 9 .
Anaesthesia and Intensive Care, Vol. 42, No. 2, March 2014 Vancomycin is predominantly eliminated by kidneys; more than 80% of the administered dose is usually excreted in an unchanged form. Therefore, maintenance doses are mainly determined by the glomerular filtration rate 8, [10] [11] [12] [13] . In many studies, renal function is estimated by calculations involving serum creatinine [14] [15] [16] . In fact, critically ill patients with a normal serum creatinine could have an increased glomerular filtration rate (GFr) [17] [18] [19] , leading to an imperfect estimation of calculated GFr by the usual formula 20, 21 .
A new equation, Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), has been reported to be more accurate and precise at higher levels of GFr 16 . The French health administration draws attention to the drug monitoring based on the Cockcroft-Gault formula and concludes:
It would be preferable to revise the summary of characteristics of the product (SCP) in order to adapt the dosage of drugs according to estimated GFR by CKD-EPI equation 22 .
The aim of this study was to determine vancomycin clearance (CL VAN ) in ICU patients during continuous infusion and to investigate its relationships with measured creatinine clearance (CL CR ), estimated creatinine clearance using the Cockcroft-Gault formula and estimated GFr according to the simplified Modification of Diet in renal Disease (MDrD) index formula and the new CKD-ePI equation, as a basis for dosing recommendations.
MATerIALS AnD MeTHoDS

Patients
This prospective, observational study involved 78 adult patients, hospitalised in the general ICU of the university Hospital of Toulouse-rangueil during a two-year period. All patients older than 15 years having infections with Gram-positive cocci bacteria (methicillin-resistant staphylococci in the majority of cases) susceptible to vancomycin were included. Patients were excluded if they had haemodynamic instability and/or shock, pregnancy, endocarditis, known allergy to glycopeptides, acute kidney injury (requiring continuous haemodiafiltration or intermittent haemodialysis) or cochleo-vestibular disorders.
The study was performed according to the Declaration of Helsinki. Concentration data are presented anonymously in accordance with ethical considerations. The local institutional research committee of our hospital gave its approval (registration number 15-0510). Since vancomycin monit-oring is part of the medical routine, the need for informed consent from patients was waived.
Vancomycin dosages and therapeutic drug monitoring
Administration of vancomycin was performed by continuous infusion in accordance with local guidelines. In this study, if the choice of antibiotic regimen was at the discretion of the clinician, published recommendations were used: 15 mg/kg loading dose followed by 30 mg/kg daily dose calculated on the total body weight with doses rounded off to 125 mg. In the case of renal failure, the loading dose was unchanged but the daily dose was adapted to the renal clearance at the discretion of the practitioner. Vancomycin serum concentrations were measured 48 hours after the beginning of the treatment. Three groups were defined in regard to the observed concentrations: less than 20 mg/l, 20 to 25 mg/l and more than 25 mg/l. When necessary, dose adjustment was carried out for a target vancomycin serum concentration ranging from 20 to 25 mg/l. Measurements were performed 48 hours after each change of dose.
Blood samples were drawn into 5 ml dry tubes, assays were performed at the Laboratory of Clinical Pharmacokinetics and Toxicology of the Federative Institute of Biology of the Purpan Hospital by using the commercialised Particle Enhanced Turbidimetric Inhibition Immunoassay, Siemens method on the rXL automate. The limit of quantification was 5 mg/l.
The intra-assay and inter-assay coefficients of variation were 3.57% and 10.43%, respectively, for a calibration curve ranging from 5 to 50 mg/l.
Biological evaluation
CL CR was measured using serum creatinine (Scr) (enzymatic assay) and the 24-hour urine output. CL CR was calculated according to the formula CL CR =(ucr×v)/Scr, where urinary creatinine (ucr) and Scr were expressed in µmol/l and v corresponded to the urinary flow rate (diuresis) in ml/minute. At the same time, the creatinine clearance has been calculated using the Cockcroft formula 14 for men, with age in years and weight in kilograms. A correcting factor of 0.85 was used for women.
GFr has been estimated by the simplified formula of the MDrD index (sMDrD) 15 At the same time we also estimated GFr according to the CKD-EPI equation 16 taking into account Scr (expressed in mg/dl), gender and ethnicity.
For white men, if Scr is lower than 0.9 mg/dl, GFr=141×(Scr/0.9) -0.411 ×(0.993) age else GFr=141×(Scr/0.9) -1.209 ×(0.993) age .
For black men, if Scr is lower than 0.9 mg/dl, GFr=163×(Scr/0.9) -0.411 ×(0.993) age else GFr=163×(Scr/0. 
Statistical evaluation
Descriptive data of each group were expressed as the mean ± standard deviation or the median and range, according to normal and non-normal distributions, respectively. Categorical variables were compared by the chi-square test with yate's correction when required.
Continuous variables were compared by using a multiple analysis of variance followed by Newman-Keuls tests.
The study of relationships between CL VAN and various biological and clinical data involved regressions. The relationship of CL VAN 
with various
GFr estimations were also compared by the Bland and Altman method. The bias and precision of the individual estimations of CL VAN by GFr estimations were evaluated according to Sheiner and Beal by the following equations 23 .
Analysis was performed with Statview stastistical software package, version 5.0 (IBM, Armonk, ny, uSA). A P value lower than 0.05 was required to achieve statistical significance.
reSuLTS
Patients
Seventy-eight patients, 55 men and 23 women, were 57±19 years old. Their characteristics are shown in Table 1 . Because of problems related to the collection of urine, CL CR could only be measured in 64 out of 78 ICU patients.
As shown in Figure 1 , admission diagnosis in ICu was polytrauma in 19 patients (15 men). For the other 59 patients (40 men), 21 patients (16 men) had postoperative complications and 38 patients (24 men) had medical pathology. Their Simplified Acute Physiology Score was 51±15 and Sequential organ Failure Assessment score was 4.6±2.3. Antibiotics were administered on average 9±11 days after admission. Sixty-seven patients were mechanically ventilated.
Dose of vancomycin
The treatment was administered for 13±6 days. The therapeutic goal was reached after 7±3 days of treatment. As shown in Table 1 , vancomycin initial dose was 29±10 mg/kg/day (2160±677 mg/day).
After the first concentration measurement, the dose had to be increased in 40 patients (group one: 51% of cases), unchanged for 25 patients (group two: 32% of cases) and reduced in 13 patients (group three: 17% of cases).
The dose adjustment, according to the admission diagnosis, is shown in Figure 1 . vancomycin dose was appropriate in 5% of trauma patients, 52% of surgical patients and 34% of medical patients. As shown in Figure 1 , the repartition in the three groups defined by the requirement of a dose modification is statistically different for the various incoming diagnoses (X² with yates correction, 4 ddl=17.181, P <0.01). The required doses according to the group are shown in Table 1 .
Pharmacokinetic parameters and influence of covariates
The analysis of the three subgroups of patients, based on the variations in vancomycin doses, shows that the various estimations of GFr and the total clearance of vancomycin were significantly different between the three groups ( Table 1) .
The highest levels of estimated GFr were found in trauma patients. In fact, the 19 trauma patients of the study had a GFr estimated by CKD-EPI equation equal to 110±30 ml/minute versus 80±31 ml/minute for the 59 other patients (P=0.0005) and were younger (47±29 versus 63±16 years for other patients). The dose required in the trauma patients was 48.5±15 mg/kg/day versus 32±16 mg/kg/ day for the other ICU patients (P <0.0001).
The simple regression analysis found a negative relationship between CL VAN , age and Simplified Acute Physiology Score II. A positive relationship was observed between CL VAN and estimated GFr by measured CL CR (r 2 =0.4544 and P <0.0001), Cockcroft-Gault formula (r 2 =0.4911 and P <0.0001), MDRD (r 2 =0.3856 and P <0.0001) and CKD-EPI equation (r 2 =0.4707 and P < 0.0001). The respective regression equations and coefficients of determination are shown in Table 2 . Figure 2 shows the Bland and Altman plots for the four GFr estimations. The CKD-EPI equation showed the strongest correlation with CL VAN : slope is close to one, although it was statistically different and one is not included in the confidence interval. But the y-intercept is not statistically different from 0 and 0 is included within the b confidence interval. These regression charact- Group 1: subgroup whose dose of vancomycin was increased between D1 and tD, Group 2: subgroup whose dose of vancomycin was unchanged between D1 and tD, Group 3: subgroup whose dose of vancomycin was decreased between D1 and tD. D1=initial dose of vancomycin administered on day one, SD=standard deviation, Css=steadystate concentrations, SAPS II=Simplified Acute Physiology Score, CL CR =creatinine clearance, sMDRD=simplified eristics have not been achieved with other GFr estimating equations. on Bland and Altman plots, measured CL CR has the lowest bias and the CKD-EPI equation presents the narrowest confidence interval.
The best precision of CL VAN estimation was observed with CKD-EPI (25.9) compared with those obtained with measured CL CR (28.5), Cockcroft formula (31.9) and MDRD (38.6).
When age, Simplified Acute Physiology Score II and CKD-EPI are taken into account, the stepwise processes show that the CL VAN is only linked to CDK-EPI (P <0.02).
DISCuSSIon
In our study, the used steady-state target plasma concentration of 20 mg/l of vancomycin after continuous infusion meets the recommendations found in the literature 7, 8, 13, 24 . The ratio of area under the curve of plasma concentrations on the MIC (area under the curve/MIC) higher than 400 is predictive of clinical efficacy 25 . Such a 20 mg/l target concentration has been designed to reach the pharmacodynamic target for strains with an MIC lower than or equal to 1 mg/l.
In more than 50% of cases in our study, the required dose was higher than doses usually used outside the ICU. These observations are in accordance with the recent data of Baptista, revilla, roberts and Li, who report that a conventional dosing regimen is probably suboptimal in adult ICU patients 11, 13, 26, 27 . As described by Roberts, our ICU patients often require at least 35 mg/kg per day to maintain the target concentration 13 . In fact, when regarding the dose requirement with respect to the admission diagnosis, most of the polytrauma and medical patients required a dose increase, while 50% of surgical patients received the right dose as shown in Figure 1 . younger patients with high glomerular filtration rate, especially polytrauma patients, required doses higher than 45 mg/kg. In practice, the target dose is directly related to the total clearance of vancomycin according to the equation Css=K0/CL VAN , where K0 is the infusion rate (mg/hour).
All the recent studies evidenced the relationship between CL VAN and CL CR 8, 11, 13, 28, 29 . The renal clearance of vancomycin is approximately 50 to 80% of CL CR , suggesting that the primary route of renal excretion is glomerular filtration, but tubular transport cannot be excluded 28 .
Kees reported in 25 ICU patients that the correlation of CL VAN with measured CL CR was very good. The relationship was rather poor with the Cockcroft-Gault formula and acceptable but lower with the Hoek formula 8 .
our study compares GFr estimated by measured CL CR , the Cockcroft-Gault formula and the CKD-EPI equation as determinants of CL VAN in critically ill patients. It is necessary to notice that the CKD-EPI equation has never been studied for vancomycin monitoring.
In the literature, many diagrams and nomograms provide dose adjustments relating to the level of CL CR 30, 31 . Many studies showed that derived estimates of GFr are inaccurate in the setting of actual GFr, especially for increased GFr, and should be interpreted with caution by the physician 8, 21 . In these conditions, measured CL CR seems the best estimation of GFr 21 and should be performed to accurately guide drug dosing.
It must be kept in mind that the new CKD-EPI equation 16 is reported to be more accurate and precise at higher levels of GFr than the MDrD formula, especially when GFr is higher than 60 ml/minute 16 .
Our results may be considered as surprising since CKD-EPI provides a better relationship with CL VAN than measured CL CR. It could not be excluded that this observation is related to the lack of measured CL CR in 14 patients of 78. Moreover, as shown in the Bland and Altman plots, measured CL CR provided a lower bias but a larger confidence interval and a weaker precision than CKD-ePI. However, in clinical practice, the physician has not at one's disposal the patient's measured CL CR when prescribing. So, we can consider CKD-EPI as the most predictive variable of CL VAN in ICU patients.
ConCLuSIon
This work finds that the vancomycin kinetics observed in ICU patients require a change in dosing schedules in a substantial number of patients. High doses of vancomycin are justified in more than half of the cases, mainly due to increased renal elimination. For this antibiotic, the CKD-ePI equation gives an indirect estimate of the patient's ability to excrete the antibiotic by glomerular filtration. Therefore, we propose to use CKD-EPI for prediction of CL VAN 
